Sahu Ankit Kumar, Nayer Jamshed, Aggarwal Praveen
Department of Emergency Medicine, All India Institute of Medical Sciences, New Delhi, India.
J Family Med Prim Care. 2020 Apr 30;9(4):1820-1824. doi: 10.4103/jfmpc.jfmpc_217_20. eCollection 2020 Apr.
Novel coronavirus (nCoV) is a new emerging infectious agent causing coronavirus disease 2019 (COVID-19). Since the reporting of early cases of COVID-19 from China on December 29, 2019 till March 15, 2020, it has affected 1,42,539 humans in 135 countries, including 82 cases in India. As it is a difficult task for first-contact physicians, i.e. primary care and acute care physicians, to comprehend the fast-growing knowledge about nCoV and apply for prevention and care of suspected cases of COVID-19, we have tried to provide an updated capsule review of nCoV infection and management of COVID-19. It includes the evidence-based information on epidemiological determinants (agent, host, and environment) of the disease, its clinical features, clinical and laboratory diagnosis, basic infection prevention and control measures, and clinical management of COVID-19 cases. This review also includes the succinct summary of World Health Organization and Center for Diseases Control and Prevention interim guidelines (as of March 15, 2020) on nCoV.
新型冠状病毒（nCoV）是一种新出现的传染性病原体，可导致2019冠状病毒病（COVID-19）。自2019年12月29日中国报告COVID-19早期病例至2020年3月15日，它已在135个国家感染了142539人，其中印度有82例。由于对于一线医生，即初级保健医生和急症医生而言，理解关于nCoV快速增长的知识并应用于COVID-19疑似病例的预防和护理是一项艰巨的任务，我们试图提供一份关于nCoV感染及COVID-19管理的最新简要综述。它包括关于该疾病流行病学决定因素（病原体、宿主和环境）的循证信息、其临床特征、临床和实验室诊断、基本感染预防和控制措施以及COVID-19病例的临床管理。本综述还包括世界卫生组织和疾病控制与预防中心关于nCoV的临时指南（截至2020年3月15日）的简要总结。
